European Journal of Medicinal Chemistry · 2018 · 42 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryEnzyme InhibitionHit-to-lead OptimizationLead Compound DesignLigand BindingPotency OptimizationTyrosine Kinase InhibitorsBiological Evaluation PlanningBiological Evaluation ReportEgfr InhibitionMedicinal Chemistry ApplicationsTargeted Inhibitor Design
23
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations
Medicine, Oncology, Pharmacology +13
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.5K citations · Full text
Medicine, Oncology, Pharmacology +15
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Medicine, Oncology, Pharmacology +15
The Many Roles for Fluorine in Medicinal Chemistry
William K. Hagmann · Journal of Medicinal Chemistry · 2008 · 3.6K citations · Full text